Market Access Developer

Market access is the work of getting a medicine, medical device or diagnostic paid for by the NHS and other health systems once it has been approved as safe and effective. A Market Access Developer (sometimes called a market access associate, analyst or executive) builds the evidence and commercial arguments that persuade bodies like NICE, NHS England and regional NHS commissioners that a product is worth funding - gathering clinical and cost data, preparing submission documents and value materials, and supporting colleagues who negotiate pricing and reimbursement. The job title is used fairly loosely: it appears in pharmaceutical and medtech companies, in specialist consultancies that do this work for them, and occasionally in a broader commercial sense in other sectors.

Approximate graduate salary

Typically around GBP 27,000-38,000 to start, though this varies widely by employer, sector and location - consultancies and London-based pharma roles sit towards the upper end, and some roles add a bonus on top. Treat this as a rough guide only.

What you'd actually do

Searching published clinical literature and health economics studies to pull together the evidence that a product works and represents reasonable value for money, then summarising it in a format a non-specialist reviewer can follow
Drafting and fact-checking sections of reimbursement submissions - documents sent to bodies such as NICE (the National Institute for Health and Care Excellence, which decides whether the NHS should routinely fund a treatment in England) or the SMC in Scotland
Building or updating cost models in Excel: for example, estimating how many patients in a particular NHS region would be eligible, what the current treatment pathway costs, and how the new product changes that
Producing 'value' materials for the field team - slide decks, budget impact summaries and objection-handling documents that account managers use in meetings with NHS commissioners and pharmacy leads
Tracking policy and guidance changes: new NICE appraisals, NHS formulary decisions (local lists of which medicines a trust will stock), tendering rules, and competitor approvals, and flagging what they mean for your product
Joining cross-functional meetings with medical affairs, regulatory, sales and finance colleagues, and taking actions away from them - this role sits in the middle of several departments rather than owning a process end to end
Interviewing or surveying NHS stakeholders and clinicians to understand how funding decisions are made locally, then feeding that back into strategy documents

How graduates get in

Direct entry into a junior market access, health economics or HEOR (health economics and outcomes research) role at a specialist consultancy - this is probably the most common graduate route, as consultancies hire in small annual cohorts and train on the job
Pharmaceutical and medtech graduate schemes: several large companies run commercial or 'future leaders' schemes with rotations that include market access, pricing or health policy. Competitive, and usually advertised in the autumn
Moving sideways from another function inside a pharma or device company - regulatory affairs, medical information, sales or marketing - after a year or two. Common, and often easier than getting in cold
A master's in health economics, public health, pharmacoeconomics or health policy, used as a conversion route. Not required, but it makes applications noticeably more credible if your first degree is unrelated
Internships or placement years in pharma, NHS commissioning support, or a health economics consultancy - a placement year is a strong route in and some firms recruit directly from their own placement pool
NHS or public-sector starting points, such as a commissioning, medicines optimisation or NHS graduate scheme role, then moving to industry with inside knowledge of how funding decisions actually get made

What employers ask for

A degree is expected, usually 2:1 or above, though some employers accept a 2:2 with relevant experience. The subject matters more here than in many commercial roles
Life sciences (biomedical science, pharmacology, biology), economics, mathematics/statistics, pharmacy or a health-related subject are the usual backgrounds. Economics and stats graduates are valued for the modelling side; life sciences graduates for understanding the clinical evidence. Other subjects are possible but you will need to show the quantitative or scientific angle somehow
Comfort with numbers is non-negotiable - specifically Excel, and an ability to read a clinical trial result and explain what it means. Some employers test this at interview with a short data or case exercise
A master's (health economics, pharmacoeconomics, public health, epidemiology) is common at consultancies and helpful elsewhere, but genuinely not required at many pharma employers
No single professional qualification governs this field. Some people later take short courses from health economics bodies or do a part-time MSc funded by their employer
Awareness of how the NHS is structured and funded - integrated care boards, formularies, NICE - is rarely required on day one but demonstrating it in an application sets you apart, because many candidates do not have it

Skills that matter

Reading and appraising clinical evidence

You need to judge whether a trial result is strong, what its limitations are, and how a sceptical NICE committee might attack it.

Excel modelling

Budget impact and cost-effectiveness models are built and sanity-checked in spreadsheets, and junior staff usually do a lot of the building and error-checking.

Writing for a non-specialist decision-maker

A submission or value message has to convince a committee member or NHS finance lead who has limited time and is not an expert in your product.

Understanding of how NHS funding decisions work

National approval does not guarantee local uptake, so knowing who signs off budgets in a trust or integrated care board shapes the whole strategy.

Precision and attention to detail

Submissions are scrutinised line by line and an error in a cost model or a misquoted trial figure can undermine the entire case.

Working across departments without authority

You will be chasing medical, regulatory, finance and sales colleagues for inputs when none of them report to you and all have their own deadlines.

Where it leads

First one to three years: analyst or associate level - supporting submissions, building model sections, doing literature reviews and keeping materials up to date under supervision.
Mid-level (roughly three to six years, though it varies widely): market access manager or senior consultant - owning a product or therapy area, leading a submission, presenting to internal leadership and meeting NHS stakeholders directly.
Senior: head of market access, pricing and reimbursement lead, or principal consultant - setting pricing strategy, negotiating commercial access agreements with NHS England, managing a team.
Common sideways moves: into health economics and outcomes research proper (more modelling and research), into pricing, into medical affairs, into government affairs and health policy, or into general commercial/brand management.
Longer term the route can lead to director-level commercial roles, or to global or European market access positions where UK experience is used as a template for other health systems. Timelines here vary enormously between a fast-moving consultancy and a large pharma company.

What people get wrong

“It's a sales job - 'market' and 'developer' sound like business development.”

It is mostly evidence, analysis and documentation. You are arguing a case to public bodies and NHS budget-holders using data, not selling to individual customers, and in the pharmaceutical industry what you can say is tightly constrained by the ABPI code of practice.

“Once a regulator approves a medicine, it's automatically available on the NHS.”

Approval only establishes that a product is safe and works. A separate process decides whether the NHS will pay for it, at what price and for which patients - and that process is this job. Plenty of approved products are never widely funded.

“You need a PhD or a clinical background.”

PhDs are common in health economics research teams, but plenty of market access staff come in with a bachelor's in life sciences or economics and learn the health system specifics on the job. The modelling and writing skills are more decisive than the credential.

“The work is the same wherever you do it.”

At a consultancy you work across many clients and products with tight deadlines and a lot of model-building; in-house at a manufacturer you go deep on one or two products over years and spend far more time on internal stakeholder management and field team support.

Where this varies

The title itself is inconsistent. In pharma and medtech it almost always means health system access and reimbursement, as described here. But a few employers outside healthcare - in financial services, export, telecoms or trade bodies - use 'market access' to mean opening up new geographic or regulatory markets for a product, which is closer to business development or trade policy work. Check the advert for mentions of NICE, HTA, reimbursement, payers or formularies: if they are there, it is the healthcare version. Within healthcare, consultancy work is project-based and deadline-driven across many clients, while in-house roles are slower-burning and more political. There is also a geographic split: a lot of pharma market access sits around London, the South East, Cambridge and Macclesfield, with devolved-nation roles (Scotland's SMC, Wales's AWMSG) handled by smaller specialist teams.

General guidance about the role across the UK market, not about any specific employer. Entry routes and requirements vary — always check the individual job advert.